Insider Transactions in Q3 2021 at Apellis Pharmaceuticals, Inc. (APLS)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2021
|
Federico Grossi Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+5.64%
|
$12,000
$3.76 P/Share
|
|
Sep 10
2021
|
David O. Watson General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
954
+0.95%
|
$3,816
$4.31 P/Share
|
|
Sep 10
2021
|
A. Sinclair Dunlop Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,894
+9.34%
|
$96,516
$14.0 P/Share
|
|
Aug 30
2021
|
James George Chopas VP/Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,600
+50.0%
|
-
|
|
Aug 16
2021
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
2,500
-0.37%
|
$140,000
$56.95 P/Share
|
|
Aug 16
2021
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+0.37%
|
$5,000
$2.67 P/Share
|
|
Aug 02
2021
|
Nicole D Perry Vice President - Accounting |
SELL
Open market or private sale
|
Direct |
1,000
-17.1%
|
$63,000
$63.99 P/Share
|
|
Aug 02
2021
|
Nicole D Perry Vice President - Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+14.6%
|
$3,000
$3.76 P/Share
|
|
Aug 02
2021
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
250
-0.4%
|
$15,750
$63.99 P/Share
|
|
Jul 21
2021
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,410
+1.15%
|
$57,640
$4.31 P/Share
|
|
Jul 21
2021
|
Mark Jeffrey De Long Chief Business & Strat Officer |
SELL
Open market or private sale
|
Direct |
1,000
-9.53%
|
$65,000
$65.0 P/Share
|
|
Jul 21
2021
|
Mark Jeffrey De Long Chief Business & Strat Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+8.7%
|
$15,000
$15.52 P/Share
|
|
Jul 15
2021
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
2,500
-0.37%
|
$155,000
$62.3 P/Share
|
|
Jul 15
2021
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+0.37%
|
$5,000
$2.67 P/Share
|
|
Jul 15
2021
|
Mark Jeffrey De Long Chief Business & Strat Officer |
SELL
Open market or private sale
|
Direct |
1,000
-9.53%
|
$62,000
$62.3 P/Share
|
|
Jul 15
2021
|
Mark Jeffrey De Long Chief Business & Strat Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+8.7%
|
$15,000
$15.52 P/Share
|
|
Jul 14
2021
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
500
-0.79%
|
$32,000
$64.68 P/Share
|
|
Jul 08
2021
|
Federico Grossi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
250
-0.39%
|
$16,250
$65.68 P/Share
|
|
Jul 01
2021
|
Nicole D Perry Vice President - Accounting |
SELL
Open market or private sale
|
Direct |
1,000
-17.1%
|
$64,000
$64.0 P/Share
|
|
Jul 01
2021
|
Nicole D Perry Vice President - Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+14.6%
|
$3,000
$3.76 P/Share
|